bioRxiv Science⌕ Search

Biology subjects

Myette, R. L.

Publications and source records attributed to Myette, R. L..

2 recordsLinked to original sources

Isolation of Extracellular Vesicles from Minimal Volume Ascites Fluid Using Strong Anion Exchange Magnetic Beads

Ovarian cancer (OC) remains a leading cause of gynecologic cancer mortality due to late-stage diagnosis and limited early detection strategies. Ascites fluid, a pathological hallmark of OC, is a rich source of tumor-derived extracellular vesicles (EVs) that reflect the tumor microenvironment and hold promise for biomarker discovery. However, isolating EVs from minimal ascites volumes (<100 {micro}L) poses technical challenges using conventional methods like ultracentrifugation or size-exclusion chromatography (SEC). This study explores the application of strong anion exchange (SAX) magnetic beads (Mag-Net) for efficient EV isolation from as little as 2 {micro}L of ascites fluid from both murine models and a human patient with mucinous borderline tumor. We demonstrate that SAX achieves robust EV capture at 10{micro}l of input volume, enabling comprehensive proteomic profiling and single-EV surface-enhanced Raman spectroscopy (SERS) with a >2-fold increase in proteomic depth compared to raw ascites. Notably, this study was able to identify 1000 proteins not previously annotated in Vesiclepedia for OC-derived EVs, alongside distinct SERS signatures, highlighting the potential for multiomic analysis. Comparative analysis with UC revealed enhanced proteomic depth obtained with SAX beads, albeit we also observed differential detection of canonical markers (e.g., CD9, CD81) between input volumes of ascites fluid. These findings establish SAX as a scalable, low-input platform for EV-based biomarker discovery, paving the way for improved early detection and molecular insights into OC progression.

biochemistry↗

Proteomic Signatures of Podocyte Injury Are Reflected in Urinary Extracellular Vesicles in Pediatric Nephrotic Syndrome.

Idiopathic nephrotic syndrome (NS) is a common glomerulopathy in children and presents with significant proteinuria. There are no reliable clinical or biochemical markers of disease relapse, or prognosis. Extracellular vesicles (EVs) are small, membrane-bound biological effectors released from stressed cells. We previously showed increases in podocyte-specific urinary EVs from children with disease relapse in NS, with numbers returning to near-zero in remission. Herein, we have expanded this work to evaluate puromycin aminonucleoside (PAN) injury by characterizing proteomic signatures of podocytes and their EVs in vitro. In addition, we performed data-independent proteomic analysis (DIA) to characterize changes in signatures of EVs from pediatric patients with active NS versus remission. Our key findings reveal PAN-injured podocytes increase large EV (LEV) secretion in vitro; moreover, DIA uncovered changes in cellular and LEV proteomes that were also observed in urinary LEVs from patients with active disease. Urinary LEV proteomes from children with active NS were significantly different than those in remission, highlighted by 645 and 240 unique proteins associated with disease or remission, respectively. This foundational work provides the impetus for a larger, prospective biomarker study aimed at identifying EV-specific proteins associated with relapse versus remission.

cell biology↗